NICE rejects long-acting HIV prevention treatment for NHS use
|
Lenacapavir, a twice-yearly injection to reduce the risk
of HIV infection, should not be routinely available as preventative
treatment. |
New once-weekly HIV pill matches daily treatment in phase 3 trial
Living with HIV often means taking antiretroviral treatment every day to keep the virus under control. While modern HIV medicines have made it ... View article...